Skip to content
Brand AI

Silverback Therapeutics

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2020

    Silverback Therapeutics closes $78.5 million Series B financing

    Silverback Therapeutics announced that it had closed an oversubscribed $78.5 million Series B financing round. The proceeds will support development of SBT6050 and advance its ImmunoTAC programs.

    Source